Clinical significance of Ki-67 in neoadjuvant chemotherapy for primary breast cancer as a predictor for chemosensitivity and for prognosis

被引:0
作者
Reiki Nishimura
Tomofumi Osako
Yasuhiro Okumura
Mitsuhiro Hayashi
Nobuyuki Arima
机构
[1] Kumamoto City Hospital,Department of Breast and Endocrine Surgery
[2] Kumamoto City Hospital,Department of Clinical Pathology
来源
Breast Cancer | 2010年 / 17卷
关键词
Breast cancer; Ki-67; Neoadjuvant chemotherapy; Predictive factor;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:269 / 275
页数:6
相关论文
共 50 条
  • [31] Ki-67 labeling index is a predictive marker for a pathological complete response to neoadjuvant chemotherapy in breast cancer: A meta-analysis
    Tao, Miaomiao
    Chen, Shu
    Zhang, Xianquan
    Zhou, Qi
    MEDICINE, 2017, 96 (51)
  • [32] Evaluation of ER, PgR, HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer
    R J Burcombe
    A Makris
    P I Richman
    F M Daley
    S Noble
    M Pittam
    D Wright
    S A Allen
    J Dove
    G D Wilson
    British Journal of Cancer, 2005, 92 : 147 - 155
  • [33] Evaluation of ER, PgR, HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer
    Burcombe, RJ
    Makris, A
    Richman, PI
    Daley, FM
    Noble, S
    Pittam, M
    Wright, D
    Allen, SA
    Dove, J
    Wilson, GD
    BRITISH JOURNAL OF CANCER, 2005, 92 (01) : 147 - 155
  • [34] Ki-67 and breast cancer prognosis: does it matter if Ki-67 level is examined using preoperative biopsy or postoperative specimen?
    Choi, Soon Bo
    Park, Jung Min
    Ahn, Jee Hyun
    Go, Jieon
    Kim, Jeeye
    Park, Hyung Seok
    Kim, Seung Il
    Park, Byeong-Woo
    Park, Seho
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 192 (02) : 343 - 352
  • [35] The predictive value of Ki-67 before neoadjuvant chemotherapy for breast cancer: a systematic review and meta-analysis
    Chen, Xianyu
    He, Chao
    Han, Dongdong
    Zhou, Meirong
    Wang, Quan
    Tian, Jinhui
    Li, Lun
    Xu, Feng
    Zhou, Enxiang
    Yang, Kehu
    FUTURE ONCOLOGY, 2017, 13 (09) : 843 - 857
  • [36] Ki-67 and breast cancer prognosis: does it matter if Ki-67 level is examined using preoperative biopsy or postoperative specimen?
    Soon Bo Choi
    Jung Min Park
    Jee Hyun Ahn
    Jieon Go
    Jeeye Kim
    Hyung Seok Park
    Seung Il Kim
    Byeong-Woo Park
    Seho Park
    Breast Cancer Research and Treatment, 2022, 192 : 343 - 352
  • [37] Ki-67 as a Prognostic Biomarker in Invasive Breast Cancer
    Davey, Matthew G.
    Hynes, Sean O.
    Kerin, Michael J.
    Miller, Nicola
    Lowery, Aoife J.
    CANCERS, 2021, 13 (17)
  • [38] Expression of Ki-67 and pAKT in colorectal cancer tissues and their clinical significance
    Li, Liang
    Wang, Jia
    Li, Jian'gang
    Wu, Zhiqiang
    Ma, Peili
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (05): : 4623 - 4630
  • [39] Changes in Ki-67 Labeling Indices During Neoadjuvant Chemotherapy for Advanced Ovarian Cancer Are Associated With Survival
    Poelcher, Martin
    Friedrichs, Nicolaus
    Rudlowski, Christian
    Fimmers, Rolf
    Keyver-Paik, Mignon-Denise
    Kuebler, Kirsten
    Sauerwald, Axel
    Buettner, Reinhard
    Kuhn, Walther
    Braun, Michael
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2010, 20 (04) : 555 - 560
  • [40] The role of Ki-67 in the proliferation and prognosis of breast cancer molecular classification subtypes
    Stathopoulos, George P.
    Malamos, Nikolaos A.
    Markopoulos, Christos
    Polychronis, Athanasios
    Armakolas, Athanasios
    Rigatos, Sotirios
    Yannopoulou, Anna
    Kaparelou, Maria
    Antoniou, Photini
    ANTI-CANCER DRUGS, 2014, 25 (08) : 950 - 957